Literature DB >> 16035192

Dopamine transporters in the cerebellum of mutant mice.

Panagiotis Giompres1, Foteini Delis.   

Abstract

In the central nervous system, dopamine is known to play a critical role in motor and cognitive functions. Although the cerebellum plays a role in the control of movement and posture and in cognitive functions, it has not been considered to be a dopaminergic region and the dopamine present was thought to represent a precursor of noradrenaline. However, recent evidence suggests that in the cerebellum there is a small dopaminergic element, whose properties are similar to the well characterized system of striatum. In order to better understand the functional role of this system and to delineate its specific interactions within the cerebellum, the distribution and properties of dopamine transporter (DAT) in the cerebellum of reeler and Purkinje cell degeneration (Nna1pcd) mutant mice, which are characterized by severe loss of different cell populations and abnormalities in synapse formation, have been studied. Kinetic studies revealed that [3H]dopamine is transported into cerebellar synaptosomes prepared from normal mice with affinities similar to that into striatal synaptosomes but with much lower maximal velocities. In reeler cerebellar synaptosomes the number of transport sites is significantly reduced. In Nna1pcd cerebellar synaptosomes the kinetic properties of transport of [3H]dopamine are similar to the normal. However, in vitro quantitative DAT autoradiography revealed a significantly increased binding in cerebellar nuclei, a decreased binding in molecular layer and an unaltered binding in the granule cell layer. These observations confirm a dopaminergic innervation of the cerebellum and contribute to our understanding of the intracerebellar distribution of the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16035192     DOI: 10.1080/14734220510007851

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  71 in total

1.  The development and degeneration of Purkinje cells in pcd mutant mice.

Authors:  S C Landis; R J Mullen
Journal:  J Comp Neurol       Date:  1978-01-01       Impact factor: 3.215

2.  Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter.

Authors:  V Fauchey; M Jaber; B Bloch; C Le Moine
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

3.  Reelin mRNA expression during mouse brain development.

Authors:  S N Schiffmann; B Bernier; A M Goffinet
Journal:  Eur J Neurosci       Date:  1997-05       Impact factor: 3.386

4.  Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study.

Authors:  C Strazielle; R Lalonde; C Hébert; T A Reader
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation.

Authors:  D S Melchitzky; D A Lewis
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

Review 6.  Events governing organization of postmigratory neurons: studies on brain development in normal and reeler mice.

Authors:  A M Goffinet
Journal:  Brain Res       Date:  1984-08       Impact factor: 3.252

7.  In utero cocaine-induced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons.

Authors:  L B Jones; G D Stanwood; B S Reinoso; R A Washington; H Y Wang; E Friedman; P Levitt
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

8.  Dopaminergic innervation and binding in the rat cerebellum.

Authors:  N T Panagopoulos; G C Papadopoulos; N A Matsokis
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

9.  Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.

Authors:  N T Panagopoulos; N A Matsokis; T Valcana
Journal:  J Neurosci Res       Date:  1993-08-01       Impact factor: 4.164

10.  Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.

Authors:  Michael J Hurley; Deborah C Mash; Peter Jenner
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

View more
  21 in total

1.  Pharmacological characterization and anatomical distribution of the dopamine transporter in the mouse cerebellum.

Authors:  Foteini Delis; Ada Mitsacos; Panagiotis Giompres
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

2.  Cerebellar D1DR-expressing neurons modulate the frontal cortex during timing tasks.

Authors:  Jonah Heskje; Kelsey Heslin; Benjamin J De Corte; Kyle P Walsh; Youngcho Kim; Sangwoo Han; Erik S Carlson; Krystal L Parker
Journal:  Neurobiol Learn Mem       Date:  2019-08-09       Impact factor: 2.877

Review 3.  Biomarkers for Parkinson's Disease: Recent Advancement.

Authors:  Sharvari Lotankar; Kedar S Prabhavalkar; Lokesh K Bhatt
Journal:  Neurosci Bull       Date:  2017-09-21       Impact factor: 5.203

4.  Aversion-related circuitry in the cerebellum: responses to noxious heat and unpleasant images.

Authors:  Eric A Moulton; Igor Elman; Gautam Pendse; Jeremy Schmahmann; Lino Becerra; David Borsook
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

5.  Acute Hypobaric Hypoxia Exposure Causes Neurobehavioral Impairments in Rats: Role of Brain Catecholamines and Tetrahydrobiopterin Alterations.

Authors:  Monojit Bhattacharjee; Suryaa Manoharan; Uma Maheswari Deshetty; Ekambaram Perumal
Journal:  Neurochem Res       Date:  2022-10-07       Impact factor: 4.414

6.  Physiological Whole-Brain Distribution of [18F]FDOPA Uptake Index in Relation to Age and Gender: Results from a Voxel-Based Semi-quantitative Analysis.

Authors:  Sinn-Rithy Toch; Sylvain Poussier; Emilien Micard; Marc Bertaux; Axel Van Der Gucht; Elodie Chevalier; Pierre-Yves Marie; Eric Guedj; Antoine Verger
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

7.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Synaptic vesicle fusion is modulated through feedback inhibition by dopamine auto-receptors.

Authors:  Rosaria Formisano; Mahlet D Mersha; Jeff Caplan; Abhyudai Singh; Catharine H Rankin; Nektarios Tavernarakis; Harbinder S Dhillon
Journal:  Synapse       Date:  2019-09-23       Impact factor: 2.562

9.  Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment.

Authors:  Francesco Angelucci; Paola De Bartolo; Francesca Gelfo; Francesca Foti; Debora Cutuli; Paola Bossù; Carlo Caltagirone; Laura Petrosini
Journal:  Cerebellum       Date:  2009-08-19       Impact factor: 3.847

Review 10.  Functional MRI in ADHD: a systematic literature review.

Authors:  Yannis Paloyelis; Mitul A Mehta; Jonna Kuntsi; Philip Asherson
Journal:  Expert Rev Neurother       Date:  2007-10       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.